Literature DB >> 17828305

CBAP interacts with the un-liganded common beta-subunit of the GM-CSF/IL-3/IL-5 receptor and induces apoptosis via mitochondrial dysfunction.

C-J Kao1, Y-J Chiang, P-H Chen, K-R Lin, P-I Hwang, H-F Yang-Yen, J J-Y Yen.   

Abstract

The cytoplasmic domain of the common beta-chain (betac) of the granulocyte-macrophage-colony-stimulating factor (GM-CSF)/interleukin-3 (IL-3)/IL-5 receptor contains a membrane proximal region that is sufficient to mediate ligand-dependent mitogenic activity. Within this region two motifs, designated as box 1 and box 2, are highly conserved among members of the cytokine receptor superfamily. Whereas box 1 is required for the recruitment and phosphorylation of Janus kinase-2, the function of box 2 remains largely unknown. Here, we report the identification of a novel transmembrane protein (common beta-chain associated protein (CBAP)) which directly associated with betac via the box 2 motif. Interestingly, such an association only occurred in the absence of GM-CSF in vivo. Ectopic overexpression of CBAP triggered apoptosis of factor-dependent cells via mitochondrial dysfunction, which could be inhibited by Bcl-2 overexpression. Reduced expression of endogenous CBAP by small interfering RNA did not interfere GM-CSF-activated signaling molecules, but such treatment significantly inhibited apoptosis induced by GM-CSF deprivation, but not other death stimuli. Domain mapping studies indicated that one apoptogenic domain of CBAP correlated with its ability to interact with betac. Taken together, these results suggest that CBAP modulates GM-CSF-deprivation-induced apoptosis possibly via a novel mechanism involving interaction with an un-liganded betac molecule.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17828305     DOI: 10.1038/sj.onc.1210778

Source DB:  PubMed          Journal:  Oncogene        ISSN: 0950-9232            Impact factor:   9.867


  5 in total

1.  Overexpression of transmembrane protein 102 implicates poor prognosis and chemoresistance in epithelial ovarian carcinoma patients.

Authors:  Yi-Jou Tai; Cheng-Miao Ou; Ying-Cheng Chiang; Chi-Fang Chang; Chi-An Chen; Wen-Fang Cheng
Journal:  Am J Cancer Res       Date:  2022-09-15       Impact factor: 5.942

2.  CSF2RB Is a Unique Biomarker and Correlated With Immune Infiltrates in Lung Adenocarcinoma.

Authors:  Ningning Zhu; Yueyang Yang; Haitong Wang; Peng Tang; Hongdian Zhang; Haiyan Sun; Lei Gong; Zhentao Yu
Journal:  Front Oncol       Date:  2022-04-28       Impact factor: 5.738

3.  CBAP functions as a novel component in chemokine-induced ZAP70-mediated T-cell adhesion and migration.

Authors:  Yun-Jung Chiang; Kun-Chin Ho; Chien-Tsang Sun; Jeng-Jiann Chiu; Fang-Jen Lee; Fang Liao; Hsin-Fang Yang-Yen; Jeffrey Jong-Young Yen
Journal:  PLoS One       Date:  2013-04-19       Impact factor: 3.240

4.  CBAP promotes thymocyte negative selection by facilitating T-cell receptor proximal signaling.

Authors:  K-C Ho; Y-J Chiang; A C-Y Lai; N-S Liao; Y-J Chang; H-F Yang-Yen; J J-Y Yen
Journal:  Cell Death Dis       Date:  2014-11-13       Impact factor: 8.469

5.  CBAP modulates Akt-dependent TSC2 phosphorylation to promote Rheb-mTORC1 signaling and growth of T-cell acute lymphoblastic leukemia.

Authors:  Yun-Jung Chiang; Wei-Ting Liao; Kun-Chin Ho; Shih-Hao Wang; Yu-Guang Chen; Ching-Liang Ho; Shiu-Feng Huang; Lee-Yung Shih; Hsin-Fang Yang-Yen; Jeffrey Jong-Young Yen
Journal:  Oncogene       Date:  2018-09-28       Impact factor: 9.867

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.